Future Pharmacology,
Год журнала:
2024,
Номер
4(4), С. 825 - 852
Опубликована: Ноя. 28, 2024
The
main
proteinase
(Mpro),
or
3CLpro,
is
a
critical
enzyme
in
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
lifecycle
and
responsible
for
breaking
down
releasing
vital
functional
viral
proteins
crucial
virus
development
transmission.
As
catalytically
active
dimer,
its
dimerization
interface
has
become
an
attractive
target
antiviral
drug
development.
Recent
research
extensively
investigated
enzymatic
activity
of
Mpro,
focusing
on
role
regulating
replication
complex
significance
maturation
infectivity.
Computational
investigations
have
identified
four
druggable
pockets,
suggesting
potential
allosteric
sites
beyond
substrate-binding
region.
Empirical
validation
through
site-directed
alanine
mutagenesis
targeted
residues
both
regions
corroborated
these
predictions.
Structural
studies
can
inform
therapeutic
approaches,
with
metadynamics
simulations
shedding
light
H163
Mpro
function
providing
insights
into
dynamic
equilibrium
to
wild-type
enzyme.
Despite
efficacy
vaccines
drugs
mitigating
SARS-CoV-2
spread,
ongoing
evolution,
selective
pressures,
continued
transmission
pose
challenges,
potentially
leading
resistant
mutations.
Phylogenetic
analyses
indicated
existence
several
variations
predating
introduction
human
population,
emphasizing
likelihood
spread.
Hydrogen/deuterium-exchange
mass
spectrometry
reveals
structural
influence
mutation.
At
same
time,
clinical
trials
3CLPro
inhibitors
underscore
reduced
offer
avenues
future
exploration.
Understanding
implications
mutations
holds
promise
shaping
forthcoming
strategies
against
COVID-19.
This
review
delves
factors
influencing
mutation
rates
identifies
areas
warranting
further
investigation,
comprehensive
overview
mutations,
categorization,
terminology.
Moreover,
we
examine
their
associations
outcomes,
illness
severity,
unresolved
issues,
prospects,
including
impact
vaccine
targeting.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Сен. 2, 2022
The
heterogeneous
nuclear
ribonucleoproteins
(hnRNPs)
are
a
diverse
family
of
RNA
binding
proteins
that
implicated
in
metabolism,
such
as
alternative
splicing,
mRNA
stabilization
and
translational
regulation.
According
to
their
different
cellular
localization,
hnRNPs
display
multiple
functions.
Most
were
predominantly
located
the
nucleus,
but
some
them
could
redistribute
cytoplasm
during
virus
infection.
HnRNPs
consist
domains
motifs
enable
these
recognize
predetermined
nucleotide
sequences.
In
virus-host
interactions,
specifically
bind
viral
or
proteins.
And
protein-hnRNP
interactions
require
other
host
factors
intermediate.
Through
various
mechanisms,
regulate
translation,
genome
replication,
switch
translation
replication
virion
release.
This
review
highlights
common
features
distinguish
roles
life
cycle
positive
single-stranded
viruses.
Emerging Microbes & Infections,
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 7, 2024
The
public's
health
is
gravely
at
risk
due
to
the
current
global
outbreak
of
emerging
viruses,
specifically
SARS-CoV-2
and
MPXV.
Recent
studies
have
shown
that
mutants
(such
as
Omicron)
exhibit
a
higher
capability
antagonize
host
innate
immunity,
increasing
their
human
adaptability
transmissibility.
Furthermore,
on
strategies
for
MPXV
immunity
are
still
in
initial
stages.
These
multiple
threats
from
viruses
make
it
urgent
study
virus-host
interactions,
especially
viral
antagonism
antiviral
immunity.
Given
this,
we
selected
several
representative
significantly
threatened
public
interpreted
these
hoping
provide
ideas
molecular
mechanism
research
accelerate
progress.
IAV,
SARS-CoV-2,
SARS-CoV,
MERS-CoV,
EBOV,
DENV,
ZIKV,
HIV
some
typical
viruses.
Studies
could
by
directly
or
indirectly
blocking
immune
signaling
pathways.
Proviral
factors,
restriction
ncRNAs
(microRNAs,
lncRNAs,
circRNAs,
vtRNAs)
essential
via
controlling
apoptosis,
ER
stress,
stress
granule
formation,
metabolic
pathways,
may
it.
regulatory
mechanisms
include
transcriptional
regulation,
post-translational
preventing
complex
impeding
nuclear
translocation,
cleavage,
degradation,
epigenetic
regulation.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(7), С. 6371 - 6371
Опубликована: Март 28, 2023
The
emergence
of
the
SARS-CoV-2
coronavirus
has
garnered
global
attention
due
to
its
highly
pathogenic
nature
and
resulting
health
crisis
economic
burden.
Although
drugs
such
as
Remdesivir
have
been
considered
a
potential
cure
by
targeting
virus
on
RNA
polymerase,
high
mutation
rate
unique
3'
5'
exonuclease
with
proofreading
function
make
it
challenging
develop
effective
anti-coronavirus
drugs.
As
result,
there
is
an
increasing
focus
host-virus
interactions
because
coronaviruses
trigger
stress
responses,
cell
cycle
changes,
apoptosis,
autophagy,
dysregulation
immune
inflammation
in
host
cells.
p53
tumor
suppressor
molecule
critical
regulator
signaling
pathways,
cellular
DNA
repair,
apoptosis.
However,
viruses
can
activate
or
inhibit
during
viral
infections
enhance
replication
spread.
Given
pivotal
role
physiology,
represents
target
for
This
review
aims
summarize
relationship
between
from
various
perspectives,
shed
light
targets
antiviral
drug
development
vaccine
design.
We
present
a
novel
small
molecule
antiviral
chemotype
that
was
identified
by
an
unconventional
cell-free
protein
synthesis
and
assembly-based
phenotypic
screen
for
modulation
of
viral
capsid
assembly.
Activity
PAV-431,
representative
compound
from
the
series,
has
been
validated
against
infectious
viruses
in
multiple
cell
culture
models
all
six
families
causing
most
respiratory
diseases
humans.
In
animals,
this
demonstrated
efficacious
porcine
epidemic
diarrhoea
virus
(a
coronavirus)
syncytial
paramyxovirus).
PAV-431
is
shown
to
bind
14-3-3,
known
allosteric
modulator.
However,
it
only
appears
target
subset
14-3-3
which
dynamic
multi-protein
complex
whose
components
include
proteins
implicated
life
cycles
innate
immunity.
The
composition
be
modified
upon
infection
largely
restored
treatment.
An
advanced
analog,
PAV-104,
selective
virally
target,
thereby
avoiding
host
toxicity.
Our
findings
suggest
new
paradigm
understanding,
drugging,
host–virus
interface,
leads
clinical
therapeutic
strategy
treatment
disease.
Vaccines,
Год журнала:
2025,
Номер
13(1), С. 46 - 46
Опубликована: Янв. 8, 2025
As
an
essential
type
of
vaccine,
live
attenuated
vaccines
(LAVs)
play
a
crucial
role
in
animal
disease
prevention
and
control.
Nevertheless,
developing
LAVs
faces
the
challenge
balancing
safety
efficacy.
Understanding
mechanisms
viruses
use
to
antagonize
host
antiviral
innate
immunity
may
help
precisely
regulate
vaccine
strains
maintain
strong
immunogenicity
while
reducing
their
pathogenicity.
It
improve
efficacy
LAVs,
as
well
provide
more
reliable
means
for
control
infectious
livestock
diseases.
Therefore,
exploring
viral
antagonistic
is
significant
clue
which
helps
explore
virulence
factors
(as
new
targets)
provides
vital
theoretical
basis
technical
support
development.
Among
viruses,
ASFV,
PRRSV,
PRV,
CSFV,
FMDV,
PCV,
PPV,
AIV
are
some
typical
representatives.
conduct
in-depth
research
summarize
strategies
these
viruses.
Studies
have
indicated
that
by
directly
or
indirectly
blocking
signaling
pathways.
In
addition,
also
do
this
antagonizing
restriction
targeting
replication
cycle.
Beyond
that,
via
regulating
apoptosis,
metabolic
pathways,
stress
granule
formation.
A
summary
might
understanding
pathogenic
mechanism
based
on
factors.
Viruses,
Год журнала:
2025,
Номер
17(3), С. 417 - 417
Опубликована: Март 14, 2025
Structural
virology
has
emerged
as
the
foundation
for
development
of
effective
antiviral
therapeutics.
It
is
pivotal
in
providing
crucial
insights
into
three-dimensional
frame
viruses
and
viral
proteins
at
atomic-level
or
near-atomic-level
resolution.
Structure-based
assessment
components,
including
capsids,
envelope
proteins,
replication
machinery,
host
interaction
interfaces,
instrumental
unraveling
multiplex
mechanisms
infection,
replication,
pathogenesis.
The
structural
elucidation
enzymes,
proteases,
polymerases,
integrases,
been
essential
combating
like
HIV-1
HIV-2,
SARS-CoV-2,
influenza.
Techniques
X-ray
crystallography,
Nuclear
Magnetic
Resonance
spectroscopy,
Cryo-electron
Microscopy,
Tomography
have
revolutionized
field
significantly
aided
discovery
ubiquity
chronic
infections,
along
with
emergence
reemergence
new
threats
necessitate
novel
strategies
agents,
while
extensive
diversity
their
high
mutation
rates
further
underscore
critical
need
analysis
to
aid
development.
This
review
highlights
significance
structure-based
investigations
bridging
gap
between
structure
function,
thus
facilitating
therapeutics,
vaccines,
antibodies
tackling
emerging
threats.